Cytokeratin detection as a diagnostic tool in oncology;Znaczenie cytokeratyn w rozpoznawaniu chorób nowotworowych

Polski Merkuriusz Lekarski

Volumn 23, Issue 135, 2007, Pages 209-211

  Galus, Ryszard ^a,b   Włodarski, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Katedra i Zak ad Histologii i Embriologii Centrum   (United States)

Author keywords

Bladder cancer; Breast cancer; Cytokeratins; Cytoskeleton; Lung cancer

Indexed keywords

KERATIN; TUMOR MARKER;

BLOOD; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; NEOPLASM; REVIEW;

HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; NEOPLASM METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; TUMOR MARKERS, BIOLOGICAL;

EID: 35048901528     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Alberts B., Bray D., Hopkin K. i wsp.: Cytoszkielet. W: Podstawy biologii komórki. Alberts B., Bray D., Hopkin K. i wsp. (red). Wydawnictwo naukowe PWN, Warszawa 2005, 574-607.
2. Attallah A.M., Sakr H.A., Ismail H. i wsp.: Rapid diagnosis and follow up of bladder cancer patients using urinary high molecular weight cytokeratins. World J. Urol., 2006, 24(3), 345-352.
3. Cynowska B., Słomiński J.M., Wyrwiński J.: Steźenie cytokeratyny 19 w surowicy chorych na niedrobnokomó rkowego raka płuca. Pneumnol. Alergol. Pol., 1995, 63, 615-620.
4. Goddard M. J., Wilson B., Grant J.W.: Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non-epithelial tissues. J. Clin. Pathol., 1991, 44(8), 660-663.
5. Gonzalez-Quintela A., Garcia J., Campos J. i wsp.: Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19. Alcohol., 2006, 38(1), 45-9.
6. Iwaya K., Mukai K.: Accumulation of ubiquitin-conjugated cytokeratin fragments in tumor cells. Semin. Cancer Biol., 2005, 15(4), 309-318.
7. Moll R., Franke W.W., Schiller D.L. i wsp.: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell, 1982, 31(1), 11-24.
8. Mullenix P.S., Brown T.A., Meyers M.O. i wsp.: The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer. Am. J. Surg., 2005, 189(5), 606-609.
9. Olszewska E., Lautermann J., Koc C. i wsp.: Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma. Eur. Arch. Otorhinolaryngol., 2005, 262(9), 731-736.
10. Szturmowicz M., Sakowicz A., Wiatr E. i wsp.: Ocena wartości oznaczania steżenia cytokeratyny 19 w rozpoznawaniu raka płuca. Pneumonol. Alergol. Pol., 1995, 63, 609-614.
11. Tatsumi N., Mukaisho K., Mitsufuji S. i wsp.: Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases. Dig. Dis. Sci., 2005, 50(9), 1741-1746.
12. Zarbo R.J., Gown A.M., Nagle R.B. i wsp.: Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod. Pathol., 1990, 3(4), 494-501.
13. Zhang H., Yang W., Ye Z. i wsp.: Clinical significance of cytokeratin 19 and cytokeratin 20 in predecting recurrence of bladder transitional cell carcinoma. The Chinese-German J. Clin. Oncol., 2006, 5, 132-134.